EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elucidating allergic reaction mechanisms in response to SARS ‐ CoV ‐2 mRNA vaccination in adults

Mihir M Shah iD, Janice A Layhadi, Dennis E Hourcade, William T Fulton iD, Tiak Ju Tan, Diane Dunham, Iris Chang iD, Monica S Vel, Andrea Fernandes iD, Alexandra S Lee iD, James Liu, Prabhu S Arunachalam und 24 weitere

Allergy · 2024

DOI: 10.1111/all.16231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Mihir M Shah und 35 weiteren Autor:innen. Beteiligte Einrichtung: Sean N. Parker Center for Allergy & Asthma Research, Stanford, California, USA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, SARS-CoV-2, Basophils. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

During the COVID‐19 pandemic, novel nanoparticle‐based mRNA vaccines were developed. A small number of individuals developed allergic reactions to these vaccines although the mechanisms remain undefined.

Methods

To understand COVID‐19 vaccine‐mediated allergic reactions, we enrolled 19 participants who developed allergic events within 2 h of vaccination and 13 controls, nonreactors. Using standard hemolysis assays, we demonstrated that sera from allergic participants induced stronger complement activation compared to nonallergic subjects following ex vivo vaccine exposure.

Results

Vaccine‐mediated complement activation correlated with anti‐polyethelyne glycol (PEG) IgG (but not IgM) levels while anti‐PEG IgE was undetectable in all subjects. Depletion of total IgG suppressed complement activation in select individuals. To investigate the effects of vaccine excipients on basophil function, we employed a validated indirect basophil activation test that stratified the allergic populations into high and low responders. Complement C3a and C5a receptor blockade in this system suppressed basophil response, providing strong evidence for complement involvement in vaccine‐mediated basophil activation. Single‐cell multiome analysis revealed differential expression of genes encoding the cytokine response and Toll‐like receptor (TLR) pathways within the monocyte compartment. Differential chromatin accessibility for IL‐13 and IL‐1B genes was found in allergic and nonallergic participants, suggesting that in vivo, epigenetic modulation of mononuclear phagocyte immunophenotypes determines their subsequent functional responsiveness, contributing to the overall physiologic manifestation of vaccine reactions.

Conclusion

These findings provide insights into the mechanisms underlying allergic reactions to COVID‐19 mRNA vaccines, which may be used for future vaccine strategies in individuals with prior history of allergies or reactions and reduce vaccine hesitancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19SARS-CoV-2BasophilsComplement ActivationHumansMaleFemaleAdultMiddle AgedmRNA VaccinesVaccinationHypersensitivityImmunoglobulin GAgedImmunoglobulin E

Stichwörter der Autor:innen

COVID‐19COVID‐19 vaccinesSARS‐CoV‐2mRNA vaccinespolyethylene glycolvaccine allergy

Substanzen

COVID-19 VaccinesmRNA VaccinesImmunoglobulin GImmunoglobulin E

Autor:innen und Institutionen

  • Sean N. Parker Center for Allergy & Asthma Research, Stanford, California, USA.
  • Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, Imperial College London, London, UK.
  • Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Stanford Health Library, Stanford, California, USA.
  • Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, California, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Mihir M Shah, William T Fulton, Iris Chang, Andrea Fernandes, Alexandra S Lee, Stephen J Galli, Stephen R Durham, Ioana Agache, Sharon Chinthrajah, Cezmi A Akdis, Mohamed H Shamji, Kari C Nadeau

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • NCI NIH HHS
  • NIAMS NIH HHS

Zitieren

APA

Shah, M. M., Layhadi, J. A., Hourcade, D. E., Fulton, W. T., Tan, T. J., Dunham, D., Chang, I., Vel, M. S., Fernandes, A., Lee, A. S., Liu, J., Arunachalam, P. S., Galli, S. J., Boyd, S. D., Pulendran, B., Davis, M. M., O'Hara, R., Park, H., Mitchell, L. M., …, & Nadeau, K. C. (2024). Elucidating allergic reaction mechanisms in response to SARS ‐ CoV ‐2 mRNA vaccination in adults. Allergy. https://doi.org/10.1111/all.16231

Vancouver

Shah MM, Layhadi JA, Hourcade DE, Fulton WT, Tan TJ, Dunham D, et al. Elucidating allergic reaction mechanisms in response to SARS ‐ CoV ‐2 mRNA vaccination in adults. Allergy. 2024. doi:10.1111/all.16231

BibTeX
@article{Shah2024,
  author = {Shah, Mihir M and Layhadi, Janice A and Hourcade, Dennis E and Fulton, William T and Tan, Tiak Ju and Dunham, Diane and Chang, Iris and Vel, Monica S and Fernandes, Andrea and Lee, Alexandra S and Liu, James and Arunachalam, Prabhu S and Galli, Stephen J and Boyd, Scott D and Pulendran, Bali and Davis, Mark M and O'Hara, Ruth and Park, Helen and Mitchell, Lynne M and Akk, Antonina and Patterson, Alexander and Jerath, Maya R and Monroy, Jennifer M and Ren, Zhen and Kendall, Peggy L and Durham, Stephen R and Fedina, Aleksandra and Gibbs, Bernhard F and Agache, Ioana and Chinthrajah, Sharon and Sindher, Sayantani B and Heider, Anja and Akdis, Cezmi A and Shamji, Mohamed H and Pham, Christine T N and Nadeau, Kari C},
  title = {Elucidating allergic reaction mechanisms in response to SARS ‐ CoV ‐2 mRNA vaccination in adults},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.16231}
}
Kostenlos starten →